Request for Covid-19 Impact Assessment of this Report
End-user/Technology
Healthcare centers and hospitals are the main users of this technology. Bio-implants are widely used for treatments of cardiovascular, dental, orthopedic, neurology and ophthalmic diseases. Sensory implants help in the treatment of nerve and brain disorder. Bio-implants like cardiac rhythm management (CRM), stents and prosthetic heart valves are used for the treatment of cardiovascular disorders. One of the major implication of orthopedic implant is to support the damaged bone joints. Cosmetic implants are primarily being used to maintain the aesthetic form of the body.
Market Dynamics
Advancement in bio-implant technology, rising need for less invasive surgical procedures, the aging population, increasing demand for cosmetic implants are the main driving force for the growth of the bio-implant market. On the other hand lack of awareness among people, insufficiently trained professionals, high cost, and stringent Govt. regulations are some of the primary restraints. The interaction between the implant and surrounding tissue can create complication which includes infection, pain, and inflammation. Because of these reasons many medical practitioners don't prefer bio-implants.
Market Segments
Bio-implant market can be segmented based on the product application which includes cardiovascular bio implants (i.e. stents, pacing devices), dental bio implants, orthopedic bioimplants (i.e. orthobiologics, trauma implants etc.), spinal bio impacts (i.e. thoracolumbar implants, intervertebral spacers, motion preservation implants etc.), and ophthalmology bio implants (i.e. glaucoma treatment). Apart from the above-mentioned products cosmetic implants are gaining popularity day by day. It is widely used as a follow up to mastectomy due to breast cancer.
Regional/Geographic Analysis
North America is the market leader followed by Europe and Asia Pacific. Technological advancement, venture capital investment, govt support and increasing demand ensure North America's leadership in the bio-implant market. High purchasing power and disposable income in North America and Europe also ensure the market growth. Investors and manufacturers are highly interested in Asia Pacific regions due to the presence of untapped market with lots of opportunities. Other geographic markets include South America, Japan, and Middle East & Africa.
Opportunities
Technological advancement, Govt. support and increasing awareness among people are creating lots of opportunities in the current market. Research is going on to remove the complication arising from the interaction between implant and surrounding tissues. The highest growth rate is expected to be in the Asia Pacific region in the forecasted period. Various R&D work in critical disease sector and complex surgical procedures are also creating opportunities for the market to grow.
Key Players
Some of the major players in the market include Stryker Corporation, Boston Scientific Corporation, Depuy Synthes, St. Jude Medical Inc, Tornier N.V., Medtronic, St. Jude Medical, Inc. (U.S.), Wright Medical Group, Biomet Inc, Smith and Nephew and Invibio Biomaterial Solutions.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...